Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | -2.99% | -4.41% | -16.67% |
Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call |
Sales 2024 * | 18.59M 25.41M | Sales 2025 * | 21.32M 29.14M | Capitalization | 33.6M 45.93M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
16.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.65% |
Latest transcript on Microbix Biosystems Inc.
1 day | -1.49% | ||
1 week | -2.94% | ||
Current month | -9.59% | ||
1 month | -14.29% | ||
3 months | -17.50% | ||
6 months | +17.86% | ||
Current year | -15.38% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
James Currie
DFI | Director of Finance/CFO | - | 16-10-31 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 90-09-30 |
Peter Blecher
BRD | Director/Board Member | - | 05-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.325 | -2.99% | 166 766 |
24-04-25 | 0.335 | 0.00% | 2,500 |
24-04-24 | 0.335 | 0.00% | 21,500 |
24-04-23 | 0.335 | -1.47% | 44,286 |
24-04-22 | 0.34 | 0.00% | 41,786 |
Delayed Quote Toronto S.E., April 26, 2024 at 10:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.38% | 33.6M | |
+1.72% | 42.59B | |
+8.70% | 40.65B | |
+48.66% | 40.57B | |
-11.96% | 26.77B | |
+8.83% | 24.81B | |
-24.37% | 18.17B | |
+28.00% | 12.05B | |
-2.95% | 11.7B | |
+7.63% | 11.1B |
- Stock Market
- Equities
- MBX Stock